Baxter Homechoice
Designed to enhance APD therapy from the inside out
The Homechoice Claria system represents the next generation in Homechoice, the world’s most widely prescribed APD cycler and the established market leader in 97 countries1. The Homechoice Claria APD system features the Sharesource connectivity platform, which facilitates on-demand access to precise patient data, allowing you to proactively manage patients remotely and make timely therapy decisions.
Description
Patients treated with PD have better early survival than those treated with conventional hemodialysis:
- PD may help avoid vascular access and associated morbidity
- Designed for a smoother lifestyle transition compared to
conventional hemodialysis. - Flexibility to travel
Reviews
There are no reviews yet.